Marion McCourt, EVP Commercial at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,000 shares at $1178.73 ($1.2M) on 2024-09-03, disclosed to the SEC on 2024-09-05.
Scheduled sale ($1.2M) by EVP Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2024-10-03 | $1.1M | — | Filing → |
| REGN | SELL | 2024-08-05 | $2.4M | — | Filing → |
| REGN | SELL | 2024-07-02 | $2.4M | — | Filing → |